Supplemental Subsidiary Guarantors (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2015	Aug. 01, 2014	Jul. 31, 2015	Aug. 01, 2014	Jan. 30, 2015	Oct. 31, 2014	Jan. 31, 2014	Oct. 25, 2013
Condensed Consolidating Statement of Income
Net sales	$ 792,183	$ 875,661	$ 2,306,579	$ 2,644,703
Cost of sales	574,838	623,729	1,674,987	1,879,499
Product development, selling and administrative expenses	145,215	137,259	444,571	444,822
Other (income) expense, net	(1,234)	(4,618)	(5,347)	(9,896)
Operating income	73,364	119,291	192,368	330,278
Income before income taxes	59,688	104,394	152,463	287,713
Provision (benefit) for income taxes	14,803	33,105	45,271	93,612
Net income	44,885	71,289	107,192	194,101
Comprehensive income	13,863	81,683	(10,567)	187,272
Current assets:
Cash and cash equivalents	140,900	308,042	270,191	405,709		$ 270,191		$ 405,709
Accounts receivable, net	829,536					1,059,709
Inventories	1,184,342					1,108,308
Other current assets	177,219					180,151
Total current assets	2,331,997					2,618,359
Property, plant and equipment, net	875,150					892,440
Other assets:
Other intangible assets, net	332,469					319,269
Goodwill	1,554,177					1,516,693
Deferred income taxes	74,532					70,181
Other non-current assets	163,804					180,044
Total other assets	2,124,982					2,086,187
Total assets	5,332,129					5,596,986
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	14,171					11,739
Trade accounts payable	330,838					395,945
Employee compensation and benefits	82,901					136,911
Advance payments and progress billings	297,722					285,939
Accrued warranties	56,802	63,685			$ 58,194	67,272	$ 73,602	85,732
Other accrued liabilities	212,440					265,600
Current liabilities of discontinued operations	11,582					11,582
Total current liabilities	1,006,456					1,174,988
Long-term obligations	1,256,032					1,269,541
Other liabilities:
Liabilities for postretirement benefits	18,721					19,609
Accrued pension costs	135,280					144,379
Other non-current liabilities	171,373					147,472
Total other liabilities	325,374					311,460
Shareholders’ equity	2,744,267					2,840,997
Total liabilities and shareholders’ equity	5,332,129					5,596,986
Operating Activities:
Net cash provided (used) by operating activities of continuing operations			168,714	298,321
Net cash provided (used) by operating activities of discontinued operations			0	(103)
Net cash provided by operating activities			168,714	298,218
Investing Activities:
Acquisition of businesses, net of cash acquired			(114,353)	(47,058)
Property, plant and equipment acquired	(18,026)	(24,764)	(57,821)	(69,068)
Proceeds from sale of property, plant and equipment			4,071	8,882
Other investing activities, net			625	(89)
Net cash used by investing activities			(167,478)	(107,333)
Financing Activities:
Common stock issued			2,853	10,189
Dividends paid			(58,456)	(55,334)
Repayments of term loan			0	(37,500)
Treasury stock purchased			(50,000)	(194,336)
Repayments of short term debt			(11,545)
Other financing activities, net			261	(10,319)
Net cash used by financing activities			(116,887)	(287,300)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(13,640)	(1,252)
Decrease in Cash and Cash Equivalents			(129,291)	(97,667)
Cash and Cash Equivalents at Beginning of Period			270,191	405,709
Cash and Cash Equivalents at End of Period	140,900	308,042	140,900	308,042
Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0	0	0
Cost of sales	0	0	0	0
Product development, selling and administrative expenses	12,499	7,017	36,503	35,840
Other (income) expense, net	0	0	68	(473)
Operating income	(12,499)	(7,017)	(36,571)	(35,367)
Intercompany items	16,750	15,641	50,106	48,422
Interest (expense) income, net	(16,068)	(15,614)	(47,449)	(47,495)
Income before income taxes	(11,817)	(6,990)	(33,914)	(34,440)
Provision (benefit) for income taxes	(8,654)	(5,923)	(2,739)	(15,855)
Equity in income of subsidiaries	48,048	72,356	138,367	212,686
Net income	44,885	71,289	107,192	194,101
Comprehensive income	13,863	81,683	(10,567)	187,272
Current assets:
Cash and cash equivalents	25,138	35,061	54,874	122,901		54,874		122,901
Accounts receivable, net	0					0
Inventories	0					0
Other current assets	72,794					87,945
Total current assets	97,932					142,819
Property, plant and equipment, net	22,152					23,660
Other assets:
Other intangible assets, net	0					0
Goodwill	0					0
Deferred income taxes	2,841					159
Other non-current assets	4,095,114					4,191,771
Total other assets	4,097,955					4,191,930
Total assets	4,218,039					4,358,409
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	14,063					0
Trade accounts payable	2,273					3,134
Employee compensation and benefits	4,976					11,639
Advance payments and progress billings	0					0
Accrued warranties	0					0
Other accrued liabilities	58,613					94,097
Current liabilities of discontinued operations	0					0
Total current liabilities	79,925					108,870
Long-term obligations	1,256,025					1,269,459
Other liabilities:
Liabilities for postretirement benefits	17,849					18,743
Accrued pension costs	117,596					132,448
Other non-current liabilities	2,377					(12,108)
Total other liabilities	137,822					139,083
Shareholders’ equity	2,744,267					2,840,997
Total liabilities and shareholders’ equity	4,218,039					4,358,409
Operating Activities:
Net cash provided (used) by operating activities of continuing operations				194,291
Net cash provided (used) by operating activities of discontinued operations				0
Net cash provided by operating activities			76,032	194,291
Investing Activities:
Acquisition of businesses, net of cash acquired			0	0
Property, plant and equipment acquired			(141)	(3,969)
Proceeds from sale of property, plant and equipment			942	0
Other investing activities, net			(1,227)	(82)
Net cash used by investing activities			(426)	(4,051)
Financing Activities:
Common stock issued			2,853	10,189
Dividends paid			(58,456)	(55,334)
Repayments of term loan				(37,500)
Treasury stock purchased			(50,000)	(194,336)
Other financing activities, net			261	(1,099)
Net cash used by financing activities			(105,342)	(278,080)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Decrease in Cash and Cash Equivalents			(29,736)	(87,840)
Cash and Cash Equivalents at Beginning of Period			54,874	122,901
Cash and Cash Equivalents at End of Period	25,138	35,061	25,138	35,061
Supplemental Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	430,840	520,247	1,400,258	1,495,659
Cost of sales	320,352	378,457	1,026,939	1,108,173
Product development, selling and administrative expenses	63,209	49,337	185,949	183,363
Other (income) expense, net	3,771	2,350	12,872	8,890
Operating income	43,508	90,103	174,498	195,233
Intercompany items	(30,145)	(14,897)	(75,362)	(60,625)
Interest (expense) income, net	1,907	1,055	5,242	4,595
Income before income taxes	15,270	76,261	104,378	139,203
Provision (benefit) for income taxes	997	32,720	25,502	89,828
Equity in income of subsidiaries	21,602	25,017	18,818	105,984
Net income	35,875	68,558	97,694	155,359
Comprehensive income	37,066	68,652	98,570	156,753
Current assets:
Cash and cash equivalents	1,972	7,023	16,429	20,361		16,429		20,361
Accounts receivable, net	245,241					391,672
Inventories	561,454					470,194
Other current assets	13,864					9,520
Total current assets	822,531					887,815
Property, plant and equipment, net	328,549					345,117
Other assets:
Other intangible assets, net	214,724					228,950
Goodwill	453,401					453,374
Deferred income taxes	0					0
Other non-current assets	1,978,193					2,106,760
Total other assets	2,646,318					2,789,084
Total assets	3,797,398					4,022,016
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0					11,634
Trade accounts payable	139,552					214,603
Employee compensation and benefits	31,460					58,374
Advance payments and progress billings	100,564					117,768
Accrued warranties	21,869					17,002
Other accrued liabilities	66,386					54,523
Current liabilities of discontinued operations	11,582					11,582
Total current liabilities	371,413					485,486
Long-term obligations	0					0
Other liabilities:
Liabilities for postretirement benefits	872					866
Accrued pension costs	8,659					7,529
Other non-current liabilities	7,343					7,780
Total other liabilities	16,874					16,175
Shareholders’ equity	3,409,111					3,520,355
Total liabilities and shareholders’ equity	3,797,398					4,022,016
Operating Activities:
Net cash provided (used) by operating activities of continuing operations				(4,062)
Net cash provided (used) by operating activities of discontinued operations				(103)
Net cash provided by operating activities			14,392	(4,165)
Investing Activities:
Acquisition of businesses, net of cash acquired			0	0
Property, plant and equipment acquired			(17,429)	(15,317)
Proceeds from sale of property, plant and equipment			214	7,124
Other investing activities, net			0	232
Net cash used by investing activities			(17,215)	(7,961)
Financing Activities:
Common stock issued			0	0
Dividends paid			0	0
Repayments of term loan				0
Treasury stock purchased			0	0
Repayments of short term debt			(11,634)
Other financing activities, net			0	(1,212)
Net cash used by financing activities			(11,634)	(1,212)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Decrease in Cash and Cash Equivalents			(14,457)	(13,338)
Cash and Cash Equivalents at Beginning of Period			16,429	20,361
Cash and Cash Equivalents at End of Period	1,972	7,023	1,972	7,023
Supplemental Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	611,006	564,148	1,616,442	1,803,084
Cost of sales	448,222	414,784	1,191,499	1,308,371
Product development, selling and administrative expenses	69,507	80,905	222,119	225,619
Other (income) expense, net	(5,005)	(6,968)	(18,287)	(18,313)
Operating income	98,282	75,427	221,111	287,407
Intercompany items	(6,865)	(7,048)	(35,306)	(19,053)
Interest (expense) income, net	485	(338)	2,302	335
Income before income taxes	91,902	68,041	188,107	268,689
Provision (benefit) for income taxes	22,460	6,329	22,508	19,639
Equity in income of subsidiaries	0	0	0	0
Net income	69,442	61,712	165,599	249,050
Comprehensive income	32,532	81,173	32,065	243,127
Current assets:
Cash and cash equivalents	113,790	265,958	198,888	262,447		198,888		262,447
Accounts receivable, net	600,477					684,299
Inventories	721,493					753,922
Other current assets	90,561					82,671
Total current assets	1,526,321					1,719,780
Property, plant and equipment, net	529,465					527,286
Other assets:
Other intangible assets, net	117,745					90,319
Goodwill	1,100,776					1,063,319
Deferred income taxes	71,691					70,022
Other non-current assets	2,569,176					2,640,582
Total other assets	3,859,388					3,864,242
Total assets	5,915,174					6,111,308
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	108					105
Trade accounts payable	189,013					178,208
Employee compensation and benefits	46,465					66,898
Advance payments and progress billings	212,375					193,165
Accrued warranties	34,933					50,270
Other accrued liabilities	100,545					124,244
Current liabilities of discontinued operations	0					0
Total current liabilities	583,439					612,890
Long-term obligations	7					82
Other liabilities:
Liabilities for postretirement benefits	0					0
Accrued pension costs	9,025					4,402
Other non-current liabilities	161,653					151,800
Total other liabilities	170,678					156,202
Shareholders’ equity	5,161,050					5,342,134
Total liabilities and shareholders’ equity	5,915,174					6,111,308
Operating Activities:
Net cash provided (used) by operating activities of continuing operations				108,092
Net cash provided (used) by operating activities of discontinued operations				0
Net cash provided by operating activities			78,290	108,092
Investing Activities:
Acquisition of businesses, net of cash acquired			(114,353)	(47,058)
Property, plant and equipment acquired			(40,251)	(49,782)
Proceeds from sale of property, plant and equipment			2,915	1,758
Other investing activities, net			1,852	(239)
Net cash used by investing activities			(149,837)	(95,321)
Financing Activities:
Common stock issued			0	0
Dividends paid			0	0
Repayments of term loan				0
Treasury stock purchased			0	0
Repayments of short term debt			89
Other financing activities, net			0	(8,008)
Net cash used by financing activities			89	(8,008)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(13,640)	(1,252)
Decrease in Cash and Cash Equivalents			(85,098)	3,511
Cash and Cash Equivalents at Beginning of Period			198,888	262,447
Cash and Cash Equivalents at End of Period	113,790	265,958	113,790	265,958
Eliminations
Condensed Consolidating Statement of Income
Net sales	(249,663)	(208,734)	(710,121)	(654,040)
Cost of sales	(193,736)	(169,512)	(543,451)	(537,045)
Product development, selling and administrative expenses	0	0	0	0
Other (income) expense, net	0	0	0	0
Operating income	(55,927)	(39,222)	(166,670)	(116,995)
Intercompany items	20,260	6,304	60,562	31,256
Interest (expense) income, net	0	0	0	0
Income before income taxes	(35,667)	(32,918)	(106,108)	(85,739)
Provision (benefit) for income taxes	0	(21)	0	0
Equity in income of subsidiaries	(69,650)	(97,373)	(157,185)	(318,670)
Net income	(105,317)	(130,270)	(263,293)	(404,409)
Comprehensive income	(69,598)	(149,825)	(130,635)	(399,880)
Current assets:
Cash and cash equivalents	0		0			0
Accounts receivable, net	(16,182)					(16,262)
Inventories	(98,605)					(115,808)
Other current assets	0					15
Total current assets	(114,787)					(132,055)
Property, plant and equipment, net	(5,016)					(3,623)
Other assets:
Other intangible assets, net	0					0
Goodwill	0					0
Deferred income taxes	0					0
Other non-current assets	(8,478,679)					(8,759,069)
Total other assets	(8,478,679)					(8,759,069)
Total assets	(8,598,482)					(8,894,747)
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	0					0
Trade accounts payable	0					0
Employee compensation and benefits	0					0
Advance payments and progress billings	(15,217)					(24,994)
Accrued warranties	0					0
Other accrued liabilities	(13,104)					(7,264)
Current liabilities of discontinued operations	0					0
Total current liabilities	(28,321)					(32,258)
Long-term obligations	0					0
Other liabilities:
Liabilities for postretirement benefits	0					0
Accrued pension costs	0					0
Other non-current liabilities	0					0
Total other liabilities	0					0
Shareholders’ equity	(8,570,161)					(8,862,489)
Total liabilities and shareholders’ equity	(8,598,482)					(8,894,747)
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			0
Cash and Cash Equivalents at End of Period	0		0
Consolidated
Condensed Consolidating Statement of Income
Net sales	792,183	875,661	2,306,579	2,644,703
Cost of sales	574,838	623,729	1,674,987	1,879,499
Product development, selling and administrative expenses	145,215	137,259	444,571	444,822
Other (income) expense, net	(1,234)	(4,618)	(5,347)	(9,896)
Operating income	73,364	119,291	192,368	330,278
Intercompany items	0	0	0	0
Interest (expense) income, net	(13,676)	(14,897)	(39,905)	(42,565)
Income before income taxes	59,688	104,394	152,463	287,713
Provision (benefit) for income taxes	14,803	33,105	45,271	93,612
Equity in income of subsidiaries	0	0	0	0
Net income	44,885	71,289	107,192	194,101
Comprehensive income	13,863	81,683	(10,567)	187,272
Current assets:
Cash and cash equivalents	140,900	308,042	270,191	405,709		270,191		$ 405,709
Accounts receivable, net	829,536					1,059,709
Inventories	1,184,342					1,108,308
Other current assets	177,219					180,151
Total current assets	2,331,997					2,618,359
Property, plant and equipment, net	875,150					892,440
Other assets:
Other intangible assets, net	332,469					319,269
Goodwill	1,554,177					1,516,693
Deferred income taxes	74,532					70,181
Other non-current assets	163,804					180,044
Total other assets	2,124,982					2,086,187
Total assets	5,332,129					5,596,986
Current liabilities:
Short-term borrowings, including current portion of long-term obligations	14,171					11,739
Trade accounts payable	330,838					395,945
Employee compensation and benefits	82,901					136,911
Advance payments and progress billings	297,722					285,939
Accrued warranties	56,802					67,272
Other accrued liabilities	212,440					265,600
Current liabilities of discontinued operations	11,582					11,582
Total current liabilities	1,006,456					1,174,988
Long-term obligations	1,256,032					1,269,541
Other liabilities:
Liabilities for postretirement benefits	18,721					19,609
Accrued pension costs	135,280					144,379
Other non-current liabilities	171,373					147,472
Total other liabilities	325,374					311,460
Shareholders’ equity	2,744,267					2,840,997
Total liabilities and shareholders’ equity	5,332,129					$ 5,596,986
Operating Activities:
Net cash provided (used) by operating activities of continuing operations				298,321
Net cash provided (used) by operating activities of discontinued operations				(103)
Net cash provided by operating activities			168,714	298,218
Investing Activities:
Acquisition of businesses, net of cash acquired			(114,353)	(47,058)
Property, plant and equipment acquired			(57,821)	(69,068)
Proceeds from sale of property, plant and equipment			4,071	8,882
Other investing activities, net			625	(89)
Net cash used by investing activities			(167,478)	(107,333)
Financing Activities:
Common stock issued			2,853	10,189
Dividends paid			(58,456)	(55,334)
Repayments of term loan				(37,500)
Treasury stock purchased			(50,000)	(194,336)
Repayments of short term debt			(11,545)	0
Other financing activities, net			261	(10,319)
Net cash used by financing activities			(116,887)	(287,300)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(13,640)	(1,252)
Decrease in Cash and Cash Equivalents			(129,291)	(97,667)
Cash and Cash Equivalents at Beginning of Period			270,191	405,709
Cash and Cash Equivalents at End of Period	$ 140,900	$ 308,042	$ 140,900	$ 308,042